Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence
- PMID: 36404633
- PMCID: PMC9762853
- DOI: 10.1080/21645515.2022.2149015
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Comment in
-
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Author's reply to correspondence.Hum Vaccin Immunother. 2023 Dec 31;19(1):2168947. doi: 10.1080/21645515.2023.2168947. Epub 2023 Jan 19. Hum Vaccin Immunother. 2023. PMID: 36655383 Free PMC article.
Comment on
-
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Results from an active pharmacovigilance study in central Italy.Hum Vaccin Immunother. 2022 Nov 30;18(6):2126668. doi: 10.1080/21645515.2022.2126668. Epub 2022 Oct 31. Hum Vaccin Immunother. 2022. PMID: 36315849 Free PMC article.
Similar articles
-
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Author's reply to correspondence.Hum Vaccin Immunother. 2023 Dec 31;19(1):2168947. doi: 10.1080/21645515.2023.2168947. Epub 2023 Jan 19. Hum Vaccin Immunother. 2023. PMID: 36655383 Free PMC article.
-
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):859-868. doi: 10.15585/mmwr.mm7126e2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35771731
-
Severe cutaneous reaction to the messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) vaccine.N Z Med J. 2022 Oct 28;135(1564):72-76. doi: 10.26635/6965.5825. N Z Med J. 2022. PMID: 36302245
-
Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273.J Pharm Pract. 2022 Dec;35(6):947-951. doi: 10.1177/08971900211009650. Epub 2021 Apr 12. J Pharm Pract. 2022. PMID: 33840294 Review.
-
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445. BMJ. 2022. PMID: 35830976 Free PMC article. Review.
References
-
- Ripabelli G, Sammarco ML, D’Amico A, De Dona R, Iafigliola M, Parente A, Samprati N, Santagata A, Adesso C, Natale A, et al. Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: results from an active pharmacovigilance study in central Italy. Hum Vaccin Immunother. 2022. Oct 31;2126668. Online ahead of print. doi:10.1080/21645515.2022.2126668. - DOI - PMC - PubMed
-
- Čiučiulkaitė I, Möhlendick B, Thümmler L, Fisenkci N, Elsner C, Dittmer U, Siffert W, Lindemann M. GNB3 c.825c>t polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine. Front Genet. 2022. Aug 29;13:932043. doi:10.3389/fgene.2022.932043. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical